Sanbur 30 mg is a proton pump inhibitor (PPI) medication manufactured by Opsonin Pharma Ltd. in Bangladesh. It contains Dexlansoprazole, the R-enantiomer of lansoprazole, formulated as a Multiple Unit Pellet System (MUPS) tablet. This dual delayed-release formulation provides extended acid suppression, making it effective for treating various acid-related gastrointestinal conditions.